• PDF / 168,910 Bytes
• 1 Pages / 595.245 x 841.846 pts (A4) Page_size
• 67 Downloads / 159 Views

DOWNLOAD

REPORT

---

1 S

Haematological and renal toxicity: 3 case reports In a study of 55 patients (treated from April 2019 to April 2020), three patients [ages and sexes not stated] were described, who developed grade 3 haematological toxicity (1 patient), grade 1 renal toxicity (1 patient) and grade 3 renal toxicity (1 patient) during treatment with infusion of lutetium-(177lu)-oxodotreotide [177Lu-DOTATATE] 7.4GBq for gastroenteropancreatic neuroendocrine tumours [GEP-NETs; time to reactions onsets and outcomes not stated]. Scalorbi F, et al. Single-institution real-life experience of 177Lu-DOTATATE treatment in progressive, well differentiated GEPNETs. Annals of Oncology : abstr. 1180P, Sep 803506097 2020. Available from: URL: http://doi.org/10.1016/j.annonc.2020.08.1393 [abstract]

0114-9954/20/1825-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved

Reactions 10 Oct 2020 No. 1825